Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial
Michael L. Schilsky, Anna Członkowska, Massimo Zuin, David Cassiman, Carlos Twardowschy, Aurélia Poujois +24 more
The Lancet. Gastroenterology & hepatology
Abstract
Orphalan.
Concepts
PenicillamineOpen labelMedicineChelation therapyPhase (matter)